Table 3.
Psychological and neuropsychological characteristics of the study sample (n=84)
| n (%) | |
|---|---|
| Anxiety symptoms (HADS-A) | |
| None (0–7) | 50 (59.5) |
| Mild (8–10) | 20 (23.8) |
| Moderate (11–14) | 11 (13.1) |
| Severe (15–21) | 3 (3.6) |
| Depressive symptoms (BDI-II/GDS) | |
| None | 44 (53.3) |
| Mild | 14 (16.9) |
| Moderate | 13 (15.5) |
| Severe | 12 (14.3) |
| Cognitive deterioration (MMSE) | |
| 18.3≥×≤23.8 | 3 (3.6) |
| >23.8 | 81 (96.4) |
| MCI (MoCA – ES*) | |
| 0 | 8 (9.5) |
| 1 | 13 (15.5) |
| 2 | 17 (20.2) |
| 3 | 14 (16.7) |
| 4 | 32 (38.1) |
Notes:
*
ES correspond to a five-point interval scale divided as follows: 0 indicates a performance to the worst 5% of the population; 4 indicates scores higher than the median value of the whole sample; 1, 2 and 3 are obtained by dividing into three equal parts the area of the distribution between 0 and 4 (37).
Abbreviations: HADS-A, Hospital Anxiety and Depression Scale-Anxiety; BDI-II, Beck Depression Inventory-second edition; GDS, Geriatric Depression Scale; MMSE, Mini Mental State Examination; MCI, Mild Cognitive Impairment; MoCA, Montreal Cognitive Assessment; ES, equivalent scores.